Inventor · disambiguated record
Zhiwen Xu
Also filed as: XU ZHIWEN
15 granted patents·2 pending applications·159 citations·filing 2010–2024
93Inventor score
Top patents by PatentIndex Score
17 records- 0197US8404242B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesZHOU JIE·Filed 2010·Granted Mar 26, 2013·89 cites·39 claims
- 0296US11078299B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2020·Granted Aug 3, 2021·4 cites·6 claims
- 0395US8753638B2Compositions and methods comprising histidyl-TRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2013·Granted Jun 17, 2014·22 cites·26 claims
- 0492US10941214B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2019·Granted Mar 9, 2021·3 cites·4 claims
- 0592US10017582B2Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2016·Granted Jul 10, 2018·7 cites·12 claims
- 0691US10526419B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2018·Granted Jan 7, 2020·6 cites·11 claims
- 0791US9605265B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2014·Granted Mar 28, 2017·10 cites·12 claims
- 0889US11807687B2Therapeutic compositions comprising anti-NRP2 antibodiesATYR PHARMA INC·Filed 2020·Granted Nov 7, 2023·2 cites·13 claims
- 0989US8945541B2Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetasesGREENE LESLIE ANN·Filed 2011·Granted Feb 3, 2015·10 cites·12 claims
- 1086US12065495B2Compositions and methods comprising anti-NRP2 antibodiesATYR PHARMA INC·Filed 2022·Granted Aug 20, 2024·1 cites·15 claims
- 1181US11505610B2Compositions and methods comprising anti-NRP2 antibodiesATYR PHARMA INC·Filed 2019·Granted Nov 22, 2022·3 cites·12 claims
- 1280US12410253B2Compositions comprising anti-NRP2 antibodiesATYR PHARMA INC·Filed 2023·Granted Sep 9, 2025·0 cites·15 claims
- 1379US12497466B2Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activitiesATYR PHARMA INC·Filed 2021·Granted Dec 16, 2025·0 cites·7 claims
- 1478US9687533B2Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetasesATYR PHARMA INC·Filed 2014·Granted Jun 27, 2017·2 cites·8 claims
- 1574US2025074990A1Compositions and methods comprising anti-nrp2 antibodiesATYR PHARMA INC·Filed 2024·Application pending·0 cites
- 1658US10220080B2Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-tRNA synthetasesATYR PHARMA INC·Filed 2017·Granted Mar 5, 2019·0 cites·10 claims
- 1752US2014066321A1Structures of human histidyl-trna synthetase and methods of useATYR PHARMA INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhiwen Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →